Bronchospasm: Difference between revisions

Jump to navigation Jump to search
Areej (talk | contribs)
No edit summary
Umert (talk | contribs)
No edit summary
Line 30: Line 30:
*[[Allergic bronchopulmonary aspergillosis]]
*[[Allergic bronchopulmonary aspergillosis]]
*[[Anaphylatoxin]]
*[[Anaphylatoxin]]
*[[Anaphylaxis]]
*[[Aspirin]]
*[[Aspirin]]
*[[Atenolol]]
*[[Atenolol]]
Line 37: Line 36:
*[[Betaxolol]]
*[[Betaxolol]]
*[[Bronchial challenge test]]
*[[Bronchial challenge test]]
*[[Chronic Stable Angina Diagnosis]]
*[[Chronic Stable Angina Treatment]]
*[[CMR Imaging]]
*[[Cocaine]]
*[[Cocaine]]
*[[Colistin]]
*[[Colistin]]
*[[Ddx:Acidosis]]
*[[Acidosis]]
*[[Diclofenac]]
*[[Diclofenac]]
*[[Exercise Stress Testing]]
*[[Exercise Stress Testing]]
Line 53: Line 49:
*[[Ketamine]]
*[[Ketamine]]
*[[Ketorolac]]
*[[Ketorolac]]
*[[Major basic protein]]
*[[Monosodium glutamate]]
*[[Monosodium glutamate]]
*[[Nadolol]]
*[[Nadolol]]
*[[Nitrazepam]]
*[[Nitrazepam]]
*[[Non-steroidal anti-inflammatory drug]]
*[[Non-steroidal anti-inflammatory drug]]
*[[PCI Complications: Renal Failure]]
*[[Pentamidine]]
*[[Pentamidine]]
*[[Propafenone]]
*[[Propafenone]]
*[[Rapacuronium]]
*[[Rapacuronium]]
*[[Respiratory Failure]]
*[[Salmeterol oral inhalation (patient information)]]
*[[Salmeterol oral inhalation (patient information)]]
*[[Schistosoma mansoni]]
*[[Schistosoma mansoni]]
*[[Scombroid]]
*[[Scombroid]]
*[[Shock (medical)]]
*[[Shock (medical)]]
*[[ST Elevation Myocardial Infarction Aspirin Therapy]]
*[[ST Elevation Myocardial Infarction Beta Blocker Therapy]]
*[[Tetrodotoxin]]
*[[Tetrodotoxin]]
*[[Timolol]]
*[[Timolol]]

Revision as of 13:01, 20 October 2009

{{}}

WikiDoc Resources for Bronchospasm

Articles

Most recent articles on Bronchospasm

Most cited articles on Bronchospasm

Review articles on Bronchospasm

Articles on Bronchospasm in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bronchospasm

Images of Bronchospasm

Photos of Bronchospasm

Podcasts & MP3s on Bronchospasm

Videos on Bronchospasm

Evidence Based Medicine

Cochrane Collaboration on Bronchospasm

Bandolier on Bronchospasm

TRIP on Bronchospasm

Clinical Trials

Ongoing Trials on Bronchospasm at Clinical Trials.gov

Trial results on Bronchospasm

Clinical Trials on Bronchospasm at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bronchospasm

NICE Guidance on Bronchospasm

NHS PRODIGY Guidance

FDA on Bronchospasm

CDC on Bronchospasm

Books

Books on Bronchospasm

News

Bronchospasm in the news

Be alerted to news on Bronchospasm

News trends on Bronchospasm

Commentary

Blogs on Bronchospasm

Definitions

Definitions of Bronchospasm

Patient Resources / Community

Patient resources on Bronchospasm

Discussion groups on Bronchospasm

Patient Handouts on Bronchospasm

Directions to Hospitals Treating Bronchospasm

Risk calculators and risk factors for Bronchospasm

Healthcare Provider Resources

Symptoms of Bronchospasm

Causes & Risk Factors for Bronchospasm

Diagnostic studies for Bronchospasm

Treatment of Bronchospasm

Continuing Medical Education (CME)

CME Programs on Bronchospasm

International

Bronchospasm en Espanol

Bronchospasm en Francais

Business

Bronchospasm in the Marketplace

Patents on Bronchospasm

Experimental / Informatics

List of terms related to Bronchospasm

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate-editor-in-chief: Areej Tariq

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Bronchospasm is a difficulty in breathing caused by a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release (degranulation) of substances from mast cells or basophils under the influence of anaphylatoxins.

Bronchospasm appears as the feature of asthma, chronic bronchitis, anaphylaxis, and as a possible side-effect of the drug Pilocarpine (which is used to treat illness resulting from the ingestion of deadly nightshade as well as other things). The overactivity of the bronchioles' muscle is a result of exposure to a stimulus which under normal circumstances would cause little or no response. The resulting constriction and inflammation causes a narrowing of the airways and an increase in mucous production; this reduces the amount of oxygen that is available to the individual causing breathlessness, coughing and hypoxia (that can cause cyanosis).

Differential diagnosis of the causes of Bronchospasm

Template:SIB


Template:WS

de:Bronchospasmus nl:Bronchospasme